Physiogenix, Inc. Career Opportunities

Physiogenix provides preclinical research services for diabetes and cardiovascular diseases. Our services include in vivo efficacy, pharmacodynamic (PD) and pharmacokinetic (PK) studies coupled with our proprietary research models. Our team of experts deliver fast, cost-effective preclinical research services to pharmaceutical, biopharma and medical device companies.

Our team of highly trained PhD and MS scientists engage in the design and execution of your preclinical drug development program using our AALAC approved animal facilities, proprietary animal models, and in vivo surgical expertise. This results are fast delivery, cost-effective preclinical research services for pharmaceutical, biopharma and medical device companies.

It's no secret that the preclinical phase of drug development is costly and time consuming one. Outsourcing this phase of the drug development cycle can help minimize costs, meet deadlines, and fulfill the market need. Physiogenix has been able to help dozens of organizations successfully develop and progress compounds through their pipelines. We work to develop long term relationships with our clients, based on trust and communication. We have worked with 8 of the top 20 pharmaceutical companies, many of which have worked with Physiogenix on multiple studies.

We pride ourselves on working closely with our clients to develop customized research programs. We use several of our proprietary models to mimic disease progression seen in humans to more accurately translate preclinical results into clinical ones. The data we collect from your studies is delivered on a real-time basis, allowing for agile study re-composition when necessary.